Lataa...
Anticoagulant and Antiplatelet Prescribing Patterns for Patients with Atrial Fibrillation after Percutaneous Coronary Intervention
BACKGROUND: Current guidelines recommend triple antithrombotic therapy (TAT), defined as acetylsalicylic acid (ASA), clopidogrel, and warfarin, for patients with nonvalvular atrial fibrillation who have undergone percutaneous coronary intervention with stent implantation. The choice of anticoagulant...
Tallennettuna:
| Julkaisussa: | Can J Hosp Pharm |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Canadian Society of Hospital Pharmacists
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5008423/ https://ncbi.nlm.nih.gov/pubmed/27621487 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|